117 related articles for article (PubMed ID: 8943789)
1. Regulation of aromatase and sulphatase in breast tumour cells.
Purohit A; Wang DY; Ghilchik MW; Reed MJ
J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.
Purohit A; Singh A; Ghilchik MW; Reed MJ
Biochem Biophys Res Commun; 1999 Jul; 261(1):214-7. PubMed ID: 10405348
[TBL] [Abstract][Full Text] [Related]
3. Control of aromatase activity in breast tumours: the role of the immune system.
Singh A; Purohit A; Duncan LJ; Mokbel K; Ghilchik MW; Reed MJ
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):185-92. PubMed ID: 9365189
[TBL] [Abstract][Full Text] [Related]
4. Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues.
Purohit A; Ghilchik MW; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):167-72. PubMed ID: 15862962
[TBL] [Abstract][Full Text] [Related]
5. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
7. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490
[TBL] [Abstract][Full Text] [Related]
8. Control and expression of oestrone sulphatase activities in human breast cancer.
Pasqualini JR; Chetrite G; Nestour EL
J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
[TBL] [Abstract][Full Text] [Related]
9. Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines.
Ryde CM; Nicholls JE; Dowsett M
Cancer Res; 1992 Mar; 52(6):1411-5. PubMed ID: 1311630
[TBL] [Abstract][Full Text] [Related]
10. Determinants of tissue oestradiol levels in human breast cancer.
Santen RJ
Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
12. IL-6sR: release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis.
Singh A; Purohit A; Wang DY; Duncan LJ; Ghilchik MW; Reed MJ
J Endocrinol; 1995 Nov; 147(2):R9-12. PubMed ID: 7490545
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen formation in breast: clinical and biological importance.
Dowsett M; Detre S; Rowlands M; Grimshaw R
J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
15. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
17. 4- and 6-(p-Sulphamoylphenyl)androstenediones: Studies of aromatase inhibitor-based oestrone sulphatase inhibition.
Watari Y; Yamaguchi S; Takahashi M; Nagaoka M; Numazawa M
Steroids; 2010 Dec; 75(12):891-6. PubMed ID: 20546769
[TBL] [Abstract][Full Text] [Related]
18. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
19. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women.
Elsadig RE; Reimann K; Yip CH; Lai LC
Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
